Swiss National Bank’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $818K | Buy |
125,800
+18,300
| +17% | +$119K | ﹤0.01% | 2212 |
|
|
2025
Q1 | $852K | Sell |
107,500
-10,300
| -9% | -$81.7K | ﹤0.01% | 2196 |
|
|
2024
Q4 | $1.49M | Buy |
117,800
+3,000
| +3% | +$38K | ﹤0.01% | 2019 |
|
|
2024
Q3 | $1.6M | Buy |
114,800
+19,400
| +20% | +$270K | ﹤0.01% | 1987 |
|
|
2024
Q2 | $1.31M | Hold |
95,400
| – | – | ﹤0.01% | 2037 |
|
|
2024
Q1 | $1.58M | Hold |
95,400
| – | – | ﹤0.01% | 1971 |
|
|
2023
Q4 | $1.39M | Hold |
95,400
| – | – | ﹤0.01% | 2057 |
|
|
2023
Q3 | $1.17M | Sell |
95,400
-15,900
| -14% | -$195K | ﹤0.01% | 2151 |
|
|
2023
Q2 | $1.33M | Buy |
+111,300
| New | +$1.33M | ﹤0.01% | 2147 |
|